Is it possible that Dr David Mcquillan sees something in Polynovo that the "dropkicks" are missing. This is the web site for KCI Medical
http://www.kci-medical.co.uk/UK-ENG/home
These are the products
http://www.kci-medical.co.uk/UK-ENG/products
These are conditions
http://www.kci-medical.co.uk/UK-ENG/conditions
This is most important. Look at potential benefits to see the similarity and CZD are in human trials!! Another difference Polynovo is synthetic not derived from pigs.
"In 2000, Dr McQuillan joined LifeCell Corporation as the Vice-President for Research and Development (R & D). He led LifeCell’s development R & D team focusing on the creation of market-leading products for reconstructive and plastic surgery applications. Following marketing approval in 2008 for its new reconstructive tissue matrix StratticeTM, LifeCell was acquired by KCI for US$1.8 Billion. Following the acquisition, Dr McQuillan became the Senior Vice President of the Advanced Research and Technology unit at KCI. Dr McQuillan left KCI in 2011, after it was acquired by a private consortium for US$6.7 Billion."
Where could the Polynovo platform be taking CZD and of course us.
Looking forward to the next six months.
Cheers
CZD Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held